Global Intravenous Solutions Market: Size, Share, price trends And Research report 2018-2023

1

Global Intravenous Solutions Market Stimulated by
Growing Cases of Chronic Diseases
Copyright IMARC. All Rights Reserved
2
About IMARC Group
Report Description
IMARC is a leading advisor on management
strategy and market research worldwide. We
partner with clients in all sectors and regions
to identify their highest-value opportunities,
address their most critical challenges, and
transform their businesses. IMARCs information
products include major market, scientific,
economic and technological developments for
business leaders in pharmaceutical, industrial,
and high technology organizations. Market
forecasts and industry analysis for
biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and
tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Intravenous Solutions Market Stimulated
by Growing Cases of Chronic Diseases The global
intravenous solutions market has been witnessing
a steady growth over the years. This can be
accredited to the introduction of new product
variants by the manufacturers along with
increasing healthcare investments in the
developing regions. The latest report by IMARC
Group, titled Intravenous Solutions Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2017-2022, finds that
the global intravenous solution market reached a
value of more than US 7 Billion in 2016.
Intravenous solutions refer to the fluids which
are administrated into a vein by means of a steel
needle or plastic catheter. They are a
combination of essential nutrients that helps in
sustaining strength, facilitating faster recovery
and maintaining hydration levels in patients.
Intravenous solutions also help in the
homeostasis of the body by maintaining its fluid
and electrolyte balance. In addition to this,
they are extensively used by the geriatric
population and to treat people suffering from
conditions like diabetes and cancer, and
unhealthy eating habits. Request Sample of the
Report http//www.imarcgroup.com/request?typerepo
rtid891flagB
4
Report Description and Highlights
5
Report Description and Highlights
Report Description

• Highlights of the global intravenous solutions
  market
• Portable packaging of intravenous solutions is
  expected to be the major demand driver.
• North America represents the largest producer,
  accounting for the majority of the global
  production.
• The market is projected to reach a value of
  around US 11 Billion by 2022.
• The major factor driving the growth of the
  intravenous solutions market is the availability
  of intravenous products in portable packaging
  which makes it easier for consumers to use them
  in a home setting as well. Additionally, through
  innovation, vendors are able to offer premixed
  products for increased convenience and reduced
  waste and disposal costs which is further likely
  to impact the market growth. Further, with the
  rising prevalence of chronic diseases and
  gastrointestinal disorders, the adoption of
  intravenous solutions is rising among the
  consumers. Moreover, the governments in the
  developing countries are increasing the
  investment in the healthcare sector, thereby
  driving the demand for intravenous solutions.
  According to the report, the global intravenous
  solutions market is expected to reach a value of
  around US 11 Billion by 2022, exhibiting a CAGR
  of 6.5 during 2017-2022.
• Read full report _at_ http//www.imarcgroup.com/intra
  venous-solutions-market

6
Report Description and Highlights
Report Description

• On the basis of product type, the market is
  segmented into partial and total parenteral
  nutrition. The market is further segregated on
  the basis of nutrients into carbohydrates, salts
  and electrolytes, minerals, vitamins and amino
  acids. Based on region, North America currently
  holds the majority of the global intravenous
  solutions market, followed by Europe and Asia
  Pacific. Other major regions include the Middle
  East and Africa, and Latin America. On evaluating
  the competitive landscape of the market, it is
  found that the major players are Ajinomoto, B.
  Braun Melsungen, Baxter International Inc.,
  Grifols and Otsuka Pharmaceutical.
• The report by IMARC Group has examined the
  global intravenous solutions market on the basis
  ofProduct Type
• Partial Parenteral Nutrition
• Total Parenteral Nutrition
• Nutrients 
• Carbohydrates
• Salts and Electrolytes
• Minerals
• Vitamins

7
Report Description and Highlights
Report Description

• Amino Acids
• Region 
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
• Key Players 
• Ajinomoto
• B. Braun Melsungen
• Baxter International Inc.
• Grifols
• Otsuka Pharmaceutical

8
Report Description and Highlights
Report Description

2017 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
9

Contact Us